Forecast

There is no analyst data available for this company.

News Go to news feed

Tempus AI secures $1.1 billion in data contracts, shares rally

Tempus AI said it signed $1.1 billion in sealed data contracts with 70 customers in 2025, including major life-sciences firms such as AstraZeneca, Pfizer, Merck and Abbvie. The company reported revenue retention around 126% and called 2025 a record year for its Data and Applications business. Shares rose as much as 15% intraday and closed up 4.51% at $69.26. Tempus AI plans to finalize and report full 2025 financial results on an earnings call in February 2026. » More on finance.yahoo.com
Tempus AI raises FY25 guidance, cites FDA clearance and Paige acquisition as growth drivers

Tempus AI guided FY25 revenue to $1.25–$1.26 billion (about 81% YoY) and expects roughly $1.55 billion in FY26 revenue, valuing the company at ~9.16x 2026 sales. Recent catalysts include FDA clearance for its xR IVD product and the $81 million acquisition of Paige, which expand addressable markets and AI pathology capabilities. Analysts note strong revenue visibility and execution, while valuation appears supported by forward growth despite a trailing P/E around 41.5 and elevated share performance since April. » More on finance.yahoo.com
Tempus AI reaches all-time high of $98.14

Tempus AI stock climbed to an all-time high of $98.14, bringing market capitalization to about $16.16 billion. Analyst price targets range from $60 to $100; Guggenheim raised its target to $95 and H.C. Wainwright to $98. Tempus recorded revenue growth of 59.84% over the last twelve months and a 1-year performance of +96.54%. The company received FDA 510(k) clearance for the RNA-based diagnostic Tempus xR IVD and expanded its CARE program for breast cancer screening. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2023, TEMPUS CAPITAL INC. has already paid €0.034 in dividends. The last payout was in August 2023.

Financials

In the last quarter, TEMPUS CAPITAL INC. had revenue of €73.2K and net profit of -€34.56K

(EUR)	June 2026	YoY
Revenue	73.2K	2.72%
Gross profit	36.96K	2.92%
Net profit	-34.56K	11.85%
EBITDA	2.21K	243.99%

Fundamentals

Metric	Value
Market capitalization	€950.18K
Number of shares	30.48M
52-week high/low	€0.053 - €0.0249
Dividends	No
Beta	-0.04
P/E ratio	-5.95
PEG ratio	2.99
P/B ratio	0.90
P/S ratio	3.09

Company profile

Tempus Capital Inc. ist als Immobilienunternehmen in Kanada tätig. Das Immobilienportfolio des Unternehmens umfasst vier Immobilien, darunter eine Gewerbefläche, eine Gewerbeimmobilie und zwei gemischte Gewerbe-/Wohnimmobilien in Ontario. Tempus Capital Inc. wurde im Jahr 2011 gegründet und hat seinen Sitz in Burlington, Kanada.